Liu, Z., & Cao, B. (2024). Single-center retrospective analysis of second-line treatment with regorafenib in patients with advanced colorectal cancer among the COVID-19 pandemic. Journal of clinical oncology, 42(16_suppl), e15552. https://doi.org/10.1200/JCO.2024.42.16_suppl.e15552
Chicago Style (17th ed.) CitationLiu, Zhentao, and Baoshan Cao. "Single-center Retrospective Analysis of Second-line Treatment with Regorafenib in Patients with Advanced Colorectal Cancer Among the COVID-19 Pandemic." Journal of Clinical Oncology 42, no. 16_suppl (2024): e15552. https://doi.org/10.1200/JCO.2024.42.16_suppl.e15552.
MLA (9th ed.) CitationLiu, Zhentao, and Baoshan Cao. "Single-center Retrospective Analysis of Second-line Treatment with Regorafenib in Patients with Advanced Colorectal Cancer Among the COVID-19 Pandemic." Journal of Clinical Oncology, vol. 42, no. 16_suppl, 2024, p. e15552, https://doi.org/10.1200/JCO.2024.42.16_suppl.e15552.